Inflammatory Bowel Disease Treatment Market By Type, Drug Case, Route of Administration, Distribution Channel & Region | Forecast 2022 to 2032

Name: Inflammatory Bowel Disease Treatment Market By Type, Drug Case, Route of Administration, Distribution Channel & Region | Forecast 2022 to 2032
Creator: www.futuremarketinsights.com
License: 暂无描述

www.futuremarketinsights.com2025-03-25 收录

下载链接：

https://www.futuremarketinsights.com/reports/inflammatory-bowel-disease-treatment-market

下载链接

链接失效反馈

官方服务：

资源简介：

<p>In 2021, the <strong>Global Inflammatory Bowel Disease Treatment</strong> market was worth around <strong>US$ 19.3 Billion</strong>. With the increasing expenditure incurred on Inflammatory Bowel Disease Treatment worldwide, the market is expected to reach a worth of about <strong>US$ 35.1 Billion</strong> by the end of 2032, with a projected CAGR of <strong>5.7%</strong> from 2022 to 2032. From 2017 to 2021, the Inflammatory Bowel Disease Treatment Market experienced a growth of 4.7%.</p><table><tbody><tr><th scope='row'>Attributes</th><td>Details</td></tr><tr><th scope='row'>Global Inflammatory Bowel Disease Treatment Market Size (2021)</th><td>US$ 19.3 Billion</td></tr><tr><th scope='row'>Global Inflammatory Bowel Disease Treatment Market Size (2022)</th><td>US$ 20.2 Billion</td></tr><tr><th scope='row'>Projected Market Value (2032)</th><td>US$ 35.1 Billion</td></tr><tr><th scope='row'>Global Market Growth Rate (2022 to 2032)</th><td>5.7% CAGR</td></tr><tr><th scope='row'>United States Growth Rate (2022 to 2032)</th><td>6.4% CAGR</td></tr><tr><th scope='row'>Share of Top 5 Countries</th><td>61%</td></tr><tr><th scope='row'>Key Companies Profiled</th><td><ul><li>AbbVie Inc.</li><li>Biogen</li><li>Johnson & Johnson Services, Inc.</li><li>Amgen Inc.</li><li>UCB S.A.</li><li>Novartis AG</li><li>Takeda Pharmaceutical Company Limited</li><li>Merck & Co., Inc.</li><li>Pfizer Inc.</li><li>Eli Lilly</li></ul></td></tr></tbody></table>

<p>于2021年，全球炎症性肠病治疗市场估值约为<strong>193亿美元</strong>。伴随着全球范围内对炎症性肠病治疗支出的持续增长，预计到2032年，该市场规模将达到约<strong>351亿美元</strong>，从2022年至2032年的复合年增长率预计为<strong>5.7%</strong>。在2017年至2021年期间，炎症性肠病治疗市场实现了4.7%的增长率。</p><table><tbody><tr><th scope='row'>属性</th><td>详细信息</td></tr><tr><th scope='row'>全球炎症性肠病治疗市场规模（2021年）</th><td>193亿美元</td></tr><tr><th scope='row'>全球炎症性肠病治疗市场规模（2022年）</th><td>202亿美元</td></tr><tr><th scope='row'>预测市场价值（2032年）</th><td>351亿美元</td></tr><tr><th scope='row'>全球市场增长率（2022年至2032年）</th><td>5.7% CAGR</td></tr><tr><th scope='row'>美国市场增长率（2022年至2032年）</th><td>6.4% CAGR</td></tr><tr><th scope='row'>前五国市场份额</th><td>61%</td></tr><tr><th scope='row'>主要公司概览</th><td><ul><li>AbbVie Inc.</li><li>Biogen</li><li>Johnson & Johnson Services, Inc.</li><li>Amgen Inc.</li><li>UCB S.A.</li><li>Novartis AG</li><li>Takeda Pharmaceutical Company Limited</li><li>Merck & Co., Inc.</li><li>Pfizer Inc.</li><li>Eli Lilly</li></ul></td></tr></tbody></table>

提供机构：